The development of microneedles (MNs) assisted drug delivery technologies have been
highly active for more than two decades. The minimally invasive and self-administered MN …

The poor aqueous solubility of many approved drugs and most new chemical entities poses
a challenge to drug delivery scientists working in academic and industrial labs. Despite the …

Cystic echinococcosis (CE) is a zoonosis caused by Echinococcus spp., affecting both
humans and animals' lives. Current treatment of CE by oral administration of albendazole …

Finasteride (FND) is a competitive inhibitor of 5α-reductase, an enzyme involved in benign
prostatic hyperplasia (BPH) and androgenic alopecia. FND is administered in oral, often …

Poorly soluble drugs constitute more than 60% of currently marketed pharmaceuticals with
over two‐thirds of promising new chemical entities failing to enter a clinical setting due to …

Despite the existence of a variety of contraceptive products for women, as well as decades
of research into the prevention and treatment of human immunodeficiency virus (HIV), there …

Intravitreal injections (IVT) are regarded as the gold standard for effective delivery of
hydrophobic drugs to the back of the eye. However, as a highly invasive procedure, the …

Implantable drug delivery systems offer an alternative for the treatments of long-term
conditions (ie schizophrenia, HIV, or Parkinson's disease among many others). The …

Eutectogels (Egels) are an emerging class of soft ionic materials outperforming traditional
temperature-intolerant hydrogels and costly ionogels. Due to their excellent elasticity, non …

Transdermal drug delivery is an alternative route of administration that offers avoidance of
the associated drawbacks of orally and parenterally administered hydrophobics. However …